文献速递糖尿病

UK Biobank 中 ApoB 与 LDL-C 对新发 2 型糖尿病的条件关联

Conditional Associations of ApoB and LDL‐C With Incident Type 2 Diabetes in UK Biobank: A Prospective Cohort Study
RSS 订阅 · Diabetes, Obesity and Metabolism · 2026-10-27

ApoB 与 LDL-C 高度相关(r=0.958),同时纳入模型后二者关联方向相反。结果显示给定 LDL-C 水平时 ApoB 越高则 T2D 风险越高,而给定 ApoB 水平时 LDL-C 越高则风险越低。

要点

  • ApoB 与 LDL-C 同时建模时关联方向相反,解读血脂与糖尿病风险时需区分颗粒数与胆固醇含量。
  • 给定 LDL-C 时 ApoB 每升高 10 mg/dL 与 T2D 风险增加相关。
  • 给定 ApoB 时 LDL-C 每升高 10 mg/dL 与 T2D 风险降低相关。

核心结论

  • 在 UK Biobank 前瞻性队列中,ApoB 与 LDL-C 对 2 型糖尿病新发风险的条件关联方向相反。
  • 给定 LDL-C 时较高 ApoB 与新发 T2D 风险增加相关;给定 ApoB 时较高 LDL-C 与新发 T2D 风险降低相关。

研究设计与样本

  • 使用原因特异性 Cox 模型,分别单独纳入和同时纳入两种血脂指标,并调整非血脂协变量。

主要发现

  • ApoB 与 LDL-C 高度相关,相关系数 r=0.958。
  • 单独建模时 ApoB 每升高 10 mg/dL 的 HR 为 1.059(95% CI:1.052–1.066),LDL-C 每升高 10 mg/dL 的 HR 为 1.018(95% CI:1.013–1.023)。
  • 同时建模时 ApoB 每升高 10 mg/dL 的 HR 为 1.502(95% CI:1.468–1.537),LDL-C 每升高 10 mg/dL 的 HR 为 0.759(95% CI:0.745–0.772)。
  • 额外调整心脏代谢指标与 HbA1c 后,ApoB 的 HR 为 1.151(95% CI:1.122–1.181),LDL-C 的 HR 为 0.890(95% CI:0.873–0.908)。
  • 时间变化分析中,第 1 年和第 10 年 ApoB 的 HR 分别为 1.658 和 1.464,LDL-C 的 HR 分别为 0.691 和 0.777。

关键数值与推荐

  • 暴露指标:基线 ApoB 与 LDL-C 浓度,单位均为 mg/dL,关联估计以每升高 10 mg/dL 表示。
  • 同时建模时 ApoB 的 HR 为 1.502(95% CI:1.468–1.537),LDL-C 的 HR 为 0.759(95% CI:0.745–0.772)。

临床怎么用

  • 在糖尿病风险评估中,ApoB 与 LDL-C 同时测定可提供超越单一指标的判别信息。
  • 高 ApoB 伴相对低 LDL-C 的个体可能具有更高的 T2D 发病风险,值得关注代谢状态。

局限性

  • 观察性研究无法确立因果关系,残余混杂可能影响估计。
  • ApoB 与 LDL-C 高度相关(r=0.958),同时建模的估计可能受共线性影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Aims Although closely correlated, apolipoprotein B (apoB) reflects atherogenic particle number, whereas low-density lipoprotein cholesterol (LDL-C) measures cholesterol carried by LDL particles. We examined whether their associations with incident Type 2 diabetes (T2D) diverged after accounting for each other. Materials and Methods We included UK Biobank participants recruited in 2006–2010 without identified baseline diabetes. ApoB and LDL-C were assessed in baseline blood samples, and incident T2D was ascertained through 19 December 2022. Cause-specific Cox models estimated hazard ratios (HRs) per 10 mg/dL higher concentration. Primary models used the same participants and nonlipid covariates, with each biomarker entered individually and both entered in one model. Additional analyses assessed combined metabolic adjustment and time-varying associations. Results Among 402 144 participants followed for 5.33 million person-years, 16 537 developed T2D. ApoB and LDL-C were highly correlated (r = 0.958). When modelled individually, HRs per 10 mg/dL were 1.059 (95% CI: 1.052–1.066) for apoB and 1.018 (95% CI: 1.013–1.023) for LDL-C. When included together, summary HRs over the full follow-up were 1.502 (95% CI: 1.468–1.537) for apoB and 0.759 (95% CI: 0.745–0.772) for LDL-C. Combined cardiometabolic and HbA1c adjustment attenuated both conditional associations, with HRs of 1.151 (95% CI: 1.122–1.181) for apoB and 0.890 (0.873–0.908) for LDL-C. Time-varying HRs at Years 1 and 10 were 1.658 and 1.464 for apoB, and 0.691 and 0.777 for LDL-C, respectively. Conclusions Higher apoB at a given LDL-C was associated with a higher hazard of incident T2D, whereas higher LDL-C at a given apoB was associated with a lower hazard.

来源:Diabetes, Obesity and Metabolism,查看原文。版权归原作者所有。

引用

  1. Diabetes, Obesity and Metabolism:Conditional Associations of ApoB and LDL‐C With Incident Type 2 Diabetes in UK Biobank: A Prospective Cohort Study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。